HCW BIOLOGICS INC. (HCWB)
HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata
HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata
Zai Lab Receives EMA Orphan Drug Designation for Zocilurtatug Pelitecan (Zoci) in Pulmonary Neuroendocrine Carcinomas
VitalHub Announces Deployments of Referral Management Solutions
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in Water
Verizon Breaks Industry Mold to Put Customers First
AMD and Rackspace Technology Sign Definitive Agreement for Phased Deployment of 30 MW of AMD AI Compute
TransUnion Appoints Clayton Ruebensaal as Chief Marketing and Communications Officer
Management and officers – staffing as of 16.6.26
Company presentation Q1 2026